Kansas City-based Intouch Solutions has reorganized its offerings into Intouch Group.
Current health systems built to evaluate and pay for traditional drugs are going to struggle with gene and other unusual therapies – but manufacturers can take steps before launch to define how manufacturers assess and value these new products.
The former president and founder of Palio, Mike Myers, has teamed up with the head of a Kansas City-based consumer agency to launch CrowdPharm, a crowdsourced international healthcare advertising network. Myers says he and Steve Bernstein, the head of Bernstein-Rein Advertising Inc., “were talking about just the current state of advertising agencies and what clients […]
precisioneffect acquired Big Pink, a leading European multichannel marketing healthcare agency recognized for providing strategically designed and creatively delivered campaigns to the pharmaceutical industry worldwide.
The former president and founder of Palio, Mike Myers, has teamed up with the head of a Kansas City-based consumer agency to launch CrowdPharm, a crowdsourced international healthcare advertising network.
2017 was a very good year for many of the agencies profiled in this annual directory featuring the leading healthcare communications agencies. Some reported individual setbacks, but they were still able to overcome these. As a wave of new drugs and biologics hit the market, several of the top healthcare agencies supported their launches.
As more innovative – yet even more expensive – therapies enter the U.S. market, brand marketers will have to find equally new and innovative ways to prove the value of their medicines to payers and patients, especially as insurance plans continue to put more of the cost burden on patients.
On Oct. 28, 2016, my mother, Joan Biamonte, died of complications from metastatic carcinoma of the lung. Despite having her original tumor characterized and going through a regimen of chemotherapy allegedly tailored to her tumor type, her cancer proliferated and spread into her liver and brain.
The goal of “Forever Welcome” is to help ensure that the United States is a safe place for immigrants to pursue their dreams.
Marketers continue to leverage the power of mobile devices, but have learned it’s not all about the apps.
For the pharmaceutical industry, 2016 brought new blockbusters onto the market to ease the pain of patent expirations.
Although patent expirations continue to depress revenue, AstraZeneca executives believe in the pipeline.
For Bayer, the acquisition of Monsanto is intended to build its Crop Science division; meanwhile two significant approvals and two new hires enhance progress in oncology.
Novo Nordisk executives believe that the company is on a path that will create growth in 2017 and beyond.
Pfizer is overcoming patent expirations by developing a steady new stream of products.
Sanofi executives continue to have faith in strategic plans to get the company to new heights despite continued impact from patent expirations.
Two have been around in the pharmaceutical industry for a long time, and one is a relative newcomer. In considering this year’s pharma innovators to profile, the results of their accomplishments, not how long they have been around, steered the direction of this feature. Donna Murphy, global CEO of the recently formed agency network Havas Health & You; Abraham Gutman, president and CEO of AG Mednet; and C. David Nicholson, executive VP and chief R&D officer of Allergan, are being saluted for bringing new innovations to the fields of pharmaceutical advertising, clinical trial imaging and R&D, and their accomplishments are expected to echo into the future.
Healthcare communications agency Calcium hired Damon Tutulic as senior VP, management director.
Jacob Licht has become chief operating officer of VLP Therapeutics. Licht joined VLP Therapeutics after 10 years at Emergent BioSolutions, where he most recently served as VP, Corporate Development.